Nuclear Medicine and Biology
Volume 37, Issue 8 , Pages 869-871, November 2010

Rat pancreas uptake of [11C]dihydrotetrabenazine stereoisomers

University of Michigan Medical School, Ann Arbor, MI 48109, USA

Received 3 May 2010; received in revised form 21 May 2010; accepted 1 June 2010. published online 26 July 2010.

Abstract 

(+)-α-[11C]Dihydrotetrabenazine ((+)-[11C]DTBZ), a radioligand for the vesicular monoamine transporter type 2 (VMAT2), has been previously proposed as an in vivo marker of beta-cell degeneration in the pancreas. The stereospecificity of uptake of [11C]DTBZ into rat pancreas was examined here using radiolabeled forms of the (+)- and (−)-isomers. Pancreas localization of (+)-[11C]DTBZ could be partially blocked by prior administration of unlabeled (+)-DTBZ. Pancreatic uptake of the (−)-isomer was unexpectedly high and could not be blocked by pretreatment with (+)-DTBZ, but could be significantly reduced by treatment with racemic tetrabenazine, an in vivo source of (−)-DTBZ. These studies indicate that the inactive isomer of DTBZ does not provide a mechanism for defining the nonspecific binding of (+)-DTBZ in rat pancreas.

Keywords: Vesicular transporter, Monoamine, Pancreas

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(10)00305-7

doi:10.1016/j.nucmedbio.2010.06.001

Nuclear Medicine and Biology
Volume 37, Issue 8 , Pages 869-871, November 2010